Serosep Revenue and Competitors
Estimated Revenue & Valuation
- Serosep's estimated annual revenue is currently $36.7M per year.
- Serosep's estimated revenue per employee is $155,000
Employee Data
- Serosep has 237 Employees.
Serosep's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Founder | Reveal Email/Phone |
2 | Regulatory Officer | Reveal Email/Phone |
3 | VP Strategic Development | Reveal Email/Phone |
4 | Director Sales | Reveal Email/Phone |
5 | Director Sales Marketing | Reveal Email/Phone |
6 | UK Molecular Sales Manager | Reveal Email/Phone |
7 | Distribution Sales Manager | Reveal Email/Phone |
8 | R&D Manager | Reveal Email/Phone |
9 | Quality Engineer | Reveal Email/Phone |
10 | Application Specialist | Reveal Email/Phone |
Serosep Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22.1M | 50 | -29% | $325.9M | N/A |
#2 | $36.7M | 237 | N/A | N/A | N/A |
#3 | $22.5M | 145 | -1% | N/A | N/A |
#4 | $4.2M | 27 | 13% | N/A | N/A |
#5 | $7.6M | 49 | 11% | N/A | N/A |
What Is Serosep?
Serosep Ltd is both a manufacturer and a distributor of laboratory diagnostic instruments and consumables. Initially Serosep Ltd developed a presence in the Irish market, partnering with strong brands, and supplying diagnostic equipment and consumables into pathology, veterinary and environmental laboratories. With a strong team of experienced Scientists, Microbiologists and Molecular Scientists we specialised in developing our own range of products including: real time PCR diagnostic kits for clinical microbiology (EntericBio®) fixatives for Histology (HistoPot®) water chemistry reagents (Precision®) In Oct. 2012, we launched the first diagnostic kit in the world that can detect gastroenteritis from faecal samples within 3 hours. Standard culture based testing methods require a minimum of 48 hours. Bacteria detected include Salmonella, Shigella, Campylobacter, Verotoxin E. Coli Shiga toxin 1 and Shiga toxin 2 and Clostridium difficile toxin B. labour intensive savings and rapid results provide many benefits to the hospital, scientist and patient. Product Design and Development is tailor made by Scientists from the clinical field. Laboratory Diagnostics, EntericBio®, HistoPot®, Precision®, Microbiology, Histopathology, Haematology, Immunology, Veterinary, Environmental
keywords:N/AN/A
Total Funding
237
Number of Employees
$36.7M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Serosep News
Market Segmentation of Players: Kadmon Holdings; Diapath; Leica Biosystems Nussloch; Genta Environmental; Carl Roth; Magnacol; Serosep; Thermo...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $41.2M | 258 | 49% | N/A |
#2 | $45.2M | 290 | 8% | $45.4M |
#3 | $114.4M | 339 | N/A | N/A |
#4 | $77.4M | 344 | N/A | N/A |
#5 | $151.9M | 450 | 7% | N/A |